Liu et al., 2022 - Google Patents
The global succinylation of SARS-CoV-2–infected host cells reveals drug targetsLiu et al., 2022
View HTML- Document ID
- 10483944722922913517
- Author
- Liu Q
- Wang H
- Zhang H
- Sui L
- Li L
- Xu W
- Du S
- Hao P
- Jiang Y
- Chen J
- Qu X
- Tian M
- Zhao Y
- Guo X
- Wang X
- Song W
- Song G
- Wei Z
- Hou Z
- Wang G
- Sun M
- Li X
- Lu H
- Zhuang X
- Jin N
- Zhao Y
- Li C
- Liao M
- Publication year
- Publication venue
- Proceedings of the National Academy of Sciences
External Links
Snippet
SARS-CoV-2, the causative agent of the COVID-19 pandemic, undergoes continuous evolution, highlighting an urgent need for development of novel antiviral therapies. Here we show a quantitative mass spectrometry-based succinylproteomics analysis of SARS-CoV-2 …
- 238000010613 succinylation reaction 0 title abstract description 57
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/713—Double-stranded nucleic acids or oligonucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Liu et al. | The global succinylation of SARS-CoV-2–infected host cells reveals drug targets | |
| Lewis et al. | Effects of SAHA and EGCG on growth potentiation of triple-negative breast cancer cells | |
| Song et al. | The inhibition of miR-144-3p on cell proliferation and metastasis by targeting TOP2A in HCMV-positive glioblastoma cells | |
| Icardi et al. | The Sin3a repressor complex is a master regulator of STAT transcriptional activity | |
| Zhu et al. | A feedback loop formed by ATG7/autophagy, FOXO3a/miR-145 and PD-L1 regulates stem-like properties and invasion in human bladder cancer | |
| Yang et al. | Overexpression of X-Box binding protein 1 (XBP1) correlates to poor prognosis and up-regulation of PI3K/mTOR in human osteosarcoma | |
| Dong et al. | Metformin mediated microRNA-7 upregulation inhibits growth, migration, and invasion of non-small cell lung cancer A549 cells | |
| Yang et al. | SETD1A promotes proliferation of castration-resistant prostate cancer cells via FOXM1 transcription | |
| Kim et al. | Cinobufagin suppresses melanoma cell growth by inhibiting LEF1 | |
| Shao et al. | AKT axis, miR-21, and RECK play pivotal roles in dihydroartemisinin killing malignant glioma cells | |
| Vonhögen et al. | MiR-337-3p promotes adipocyte browning by inhibiting TWIST1 | |
| Shen et al. | Potential therapies targeting metabolic pathways in cancer stem cells | |
| Windmoeller et al. | Novel primary human cancer stem-like cell populations from non-small cell lung cancer: inhibition of cell survival by targeting NF-κB and MYC signaling | |
| Schmitz et al. | Targeting hdacs in pancreatic neuroendocrine tumor models | |
| Jampasri et al. | Plumbagin suppresses breast cancer progression by downregulating HIF-1α expression via a PI3K/Akt/mTOR independent pathway under hypoxic condition | |
| Ngo et al. | A yes-associated protein (YAP) and insulin-like growth factor 1 receptor (IGF-1R) signaling loop is involved in sorafenib resistance in hepatocellular carcinoma | |
| Cherng et al. | Induced mitochondrial alteration and DNA damage via IFNGR-JAK2-STAT1-PARP1 pathway facilitates viral hepatitis associated hepatocellular carcinoma aggressiveness and stemness | |
| Coppola et al. | S-Adenosylmethionine inhibits cell growth and migration of triple negative breast cancer cells through upregulating MiRNA-34c and MiRNA-449a | |
| Zhao et al. | MiR-663a, regulated by lncRNA GAS5, contributes to osteosarcoma development through targeting MYL9 | |
| Lanzi et al. | Overactive IGF1/insulin receptors and NRASQ61R mutation drive mechanisms of resistance to pazopanib and define rational combination strategies to treat synovial sarcoma | |
| Chang et al. | miR-145-5p targets Sp1 in non-small cell lung cancer cells and links to BMI1 induced pemetrexed resistance and epithelial–mesenchymal transition | |
| Cai et al. | LncRNA SNHG1 facilitates Tumor Proliferation and represses apoptosis by regulating PPARγ ubiquitination in bladder Cancer | |
| Wu et al. | Cytoprotection against Oxidative Stress by Methylnissolin-3-O-β-d-glucopyranoside from Astragalus membranaceus Mainly via the Activation of the Nrf2/HO-1 Pathway | |
| Szymczak-Pajor et al. | Metformin induces apoptosis in human pancreatic cancer (PC) cells accompanied by changes in the levels of histone acetyltransferases (particularly, p300/CBP-associated factor (PCAF) protein levels) | |
| Wang et al. | SFN enhanced the radiosensitivity of cervical cancer cells via activating LATS2 and blocking Rad51/MDC1 recruitment to DNA damage site |